Please see the list below for VCA veterinary clinical studies enrolling patients at this time. If you have any questions about a specific clinical trial, please contact us.

 

 

Canine Enrollment

Canine Lymphoma

VetDC with participating VCA hospitals are pleased to announce a clinical study treatment of canine lymphoma with TANOVEA® -CA1 (rabacfosadine for injection), the first and only FDA conditionally approved drug for the treatment of lymphoma in dogs.

Administrations occur every three (3) weeks for up to five (5) treatments in dogs with lymphoma that has either been previously treated or untreated. In order to participate in the study, dogs must meet all eligibility criteria as confirmed by participating veterinarians. This study is fully funded by VetDC, and owners will be offered a clinic credit towards additional treatment in the event of disease progression.

Open for enrollment at:

Katonah Bedford Veterinary Center | Bedford Hills, NY
VCA Animal Diagnostic Clinic | Dallas, TX

For more information about this study, please contact us.

 

Feline Enrollment

Feline Chronic Kidney Disease Associate Anemia Study

Select VCA Hospitals are pleased to announce participation in a FDA-regulated clinical study to evaluate a novel gene therapy product for the treatment of cats with anemia due to chronic kidney disease.

Cats will receive physical exams, regular clinical pathology assessments and treatment at no charge to the owner over the period of their participation in the study. An incentive will also be provided for owners participating in the study.

Open for enrollment at:
Cat Hospital of Chicago | Chicago, IL
VCA Sacramento Veterinary Referral Center | Sacramento, CA

For more information about this study, please contact us.

Feline Lymphoma

Participating VCA hospitals are currently evaluating the safety and efficacy of rabacfosadine in cats. Rabacfosadine will be provided at no cost along with subsidized visits.

Open for enrollment at:

Katonah Bedford Veterinary Center | Bedford Hills, NY
VCA Animal Diagnostic Clinic | Dallas, TX

For more information about this study, please contact us.

 

VCA Clinical Studies – Enrollment Closed

Feline Urine Spraying and Marking Behavior Study - enrollment closed

Select VCA Hospital behavior services are currently participating in a pilot clinical study to evaluate the effectiveness and safety of an investigational veterinary product for the management of feline behavioral urine spraying.

Feline FIV Positive Blood Sample Study - enrollment closed

Serial blood sampling study for FIV positive cats to evaluate antigens. 

Feline Allergic Dermatitis - enrollment closed

Participating VCA hospitals are currently enrolling cats for a new feline anti-pruritic drug for the treatment of clinical signs associated with allergic dermatitis. This is a double-blinded, placebo-controlled study. 

Canine Malignant Tumors - enrollment closed

Select VCA hospitals are conducting a clinical study to evaluate a novel drug therapy for the treatment of malignant tumors in dogs.

Canine Vector-Borne Disease Sample Study - enrollment closed

Blood sample collection study for dogs with Lyme, Anaplasma Phagocytophilum or Ehrlichia canis.

Canine Thrombocytopenia - enrollment closed

Participating VCA hospitals are currently enrolling dogs to evaluate the safety and efficacy of StablePlate RX®

Canine Atopic Dermatitis - enrollment closed

Participating VCA hospitals are currently enrolling dogs diagnosed with atopic dermatitis for a Cytopoint® study. 

Cachexia in Dogs - enrollment closed

Tensive Controls and the University of Missouri in partnership with participating VCA hospitals is proud to announce a collaboration for the treatment of cachexia in dogs. Cachexia and anorexia syndromes are characterized by the loss of lean body mass and lack of appetite, which can lead to a significant decline in the quality of life of affected dogs. This funded clinical study is evaluating a novel drug for the treatment of cachexia in dogs, aimed at improving both appetite and metabolism. 

Canine Non-Allergic Pruritic Diseases - enrollment closed

A data collection study from blood serum tests on dogs with a variety of non-allergic pruritic diseases.

Canine Post-Vaccine Sample Study - enrollment closed

Participating VCA hospitals are currently enrolling dogs for a blood sampling study.

Canine Oral Melanoma (Stage I-II) - enrollment closed

A collaboration for the treatment of Stage I or II canine oral melanoma with Nano-Pulse Stimulation (NPS), a non-thermal, drug free tissue treatment technology currently in development.

Canine Oral Melanoma (Stage III-IV) - enrollment closed

A collaboration for the treatment of Stage III or IV canine oral melanoma with Nano-Pulse Stimulation (NPS), a non-thermal, and drug free tissue treatment technology currently in development.

Canine Bacterial Pneumonia - enrollment closed

Assess pharmacokinetic levels of Cefepime in dogs who receive a minimum of one dose of therapy for bacterial pneumonia. Eligible dogs will be provided with the first dose of Cefepime, study related laboratory testing, and hospital patient monitoring. Owners will be responsible for the usual care for the bronchoalveolar lavage procedures.

Canine Hyperadrenocorticism - enrollment closed

Canine hyperadrenocorticism, also known as Cushing Syndrome, is caused from excessive production of adrenocorticotropic hormone (ACTH) that can be caused from pituitary-dependent over production or from a functional tumor of the adrenal cortex, adrenal-dependent. Common treatment involves use of trilostane (Vetoryl).

Canine SonicGuard Device - enrollment closed

Study on the usability and effectiveness of SonicGuard's ultrasonic device to repel ticks and fleas in dogs.

Canine Osteosarcoma - enrollment closed

Study to evaluate the Canine Osteosarcoma Vaccine, Live Listeria Vector (COV-LLV), a conditionally licensed product for dogs with osteosarcoma who have undergone amputation and chemotherapy.

Feline Retrovirus Sample Study - enrollment closed

Cats presenting for FeLV/FIV screening tests or cats diagnosed with FeLV/FIV. Blood samples collected from eligible cats will be processed for additional retrovirus testing.

Canine Irritable Bowel Disease (IBD) - enrollment closed

IBD is a common cause of chronic GI disease in dogs resulting from chronic gut inflammation. The definitive diagnosis of IBD requires an endoscopy/biopsy that is a routine, but invasive, procedure. Participating VCA hospitals are currently enrolling patients to evaluate the presence and level of multiple biomarkers in the serum of dogs, which may aid in the non-invasive diagnosis of IBD and/or other gastrointestinal disorders. Dogs presenting to participating study sites will be evaluated for enrollment eligibility.

Canine Osteoarthritis - enrollment closed

Donor stem cell treatment for dogs with osteoarthritis in order to determine if a single injection of stem cells into one or two affected joints can help reduce clinical signs associated with osteoarthritis. This study is fully funded. Dogs presenting to a participating study site will be evaluated for enrollment eligibility.

Canine Mast Cell Tumor - enrollment closed

AB Science and VCA are pleased to announce a study for the indication of Kinavet for dogs with non-resectable cutaneous mast cell tumor. Dogs will be treated by Kinavet or placebo (randomization 2 : 1) for a 24-week period, followed by an extension period in case of benefit. The dog owner will be provided with treatment for free and all required medical examinations are supported by AB Science.

Canine Lymphoma, Melanoma & Mast Cell Tumor - enrollment closed

Evaluate a novel antibody-based therapy for dogs. We are looking for client-owned dogs with lymphoma, melanoma, or mast cell tumors.

Learn More

Have questions or comments regarding clinical studies? Send us an inquiry. We look forward to hearing from you!